Clinical trial of three-month TB treatment regimen closed due to high rate of unfavorable outcomes

FHS
July 5, 2023
4:22 pm

The first clinical trial of a three-month tuberculosis (TB) treatment regimen is closing enrollment because of a high rate of unfavorable outcomes with the investigational course of treatment.

Liquid Biopsy Has Mixed Performance for Predicting Colon Cancer Outcomes

SAN FRANCISCO — In separate studies, liquid biopsy produced mixed results for guiding colon cancer treatment. Adjuvant chemotherapy guided by postoperative circulating tumor (ct) DNA

January 24, 2024

Patent appeal board takes up Ozempic challenge

The US Patent and Trademark Office’s Patent Trial and Appeal Board has agreed to take another look at a patent covering certain strengths of Novo

October 5, 2023

Opinion | Preserve the National Institute of Nursing Research’s Independence

Darcy-Mahoney is a professor, neonatal nurse practitioner, researcher, and educator. Menon is the dean of a college of nursing. Murray is dean emerita, professor, and

November 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.